BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perlot T, Penninger JM. ACE2 - from the renin-angiotensin system to gut microbiota and malnutrition. Microbes Infect. 2013;15:866-873. [PMID: 23962453 DOI: 10.1016/j.micinf.2013.08.003] [Cited by in Crossref: 101] [Cited by in F6Publishing: 91] [Article Influence: 11.2] [Reference Citation Analysis]
Number Citing Articles
1 Dong ZY, Xiang BJ, Jiang M, Sun MJ, Dai C. The Prevalence of Gastrointestinal Symptoms, Abnormal Liver Function, Digestive System Disease and Liver Disease in COVID-19 Infection: A Systematic Review and Meta-Analysis. J Clin Gastroenterol. 2021;55:67-76. [PMID: 33116063 DOI: 10.1097/mcg.0000000000001424] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
2 Li S, Yang S, Zhou Y, Disoma C, Dong Z, Du A, Zhang Y, Chen Y, Huang W, Chen J, Song D, Chen Z, Liu P, Li S, Zheng R, Liu S, Razzaq A, Chen X, Tao S, Yu C, Feng T, Liao W, Peng Y, Jiang T, Huang J, Wu W, Hu L, Wang L, Li S, Xia Z. Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota. Front Microbiol 2021;12:712081. [PMID: 34707577 DOI: 10.3389/fmicb.2021.712081] [Reference Citation Analysis]
3 Venegas-Borsellino C, Sankararaman S, Roche K, Burns J, Landis RM. Impact of COVID-19 on the Intestinal Microbiome. Curr Nutr Rep 2021;10:300-6. [PMID: 34813042 DOI: 10.1007/s13668-021-00375-z] [Reference Citation Analysis]
4 Parajuli N, Ramprasath T, Patel VB, Wang W, Putko B, Mori J, Oudit GY. Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases. Can J Physiol Pharmacol 2014;92:558-65. [PMID: 24861775 DOI: 10.1139/cjpp-2013-0488] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
5 Sparks MA, Crowley SD, Gurley SB, Mirotsou M, Coffman TM. Classical Renin-Angiotensin system in kidney physiology. Compr Physiol 2014;4:1201-28. [PMID: 24944035 DOI: 10.1002/cphy.c130040] [Cited by in Crossref: 229] [Cited by in F6Publishing: 208] [Article Influence: 32.7] [Reference Citation Analysis]
6 Hussain I, Cher GLY, Abid MA, Abid MB. Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential. Front Immunol 2021;12:765965. [PMID: 34721437 DOI: 10.3389/fimmu.2021.765965] [Reference Citation Analysis]
7 Villapol S. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. Transl Res 2020;226:57-69. [PMID: 32827705 DOI: 10.1016/j.trsl.2020.08.004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 33.5] [Reference Citation Analysis]
8 Reinold J, Farahpour F, Fehring C, Dolff S, Konik M, Korth J, van Baal L, Hoffmann D, Buer J, Witzke O, Westendorf AM, Kehrmann J. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19. Front Cell Infect Microbiol 2021;11:747816. [PMID: 34869058 DOI: 10.3389/fcimb.2021.747816] [Reference Citation Analysis]
9 Devaux CA, Lagier JC, Raoult D. New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness. Front Med (Lausanne) 2021;8:640073. [PMID: 33681266 DOI: 10.3389/fmed.2021.640073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
10 Bhattarai A, Pawnikar S, Miao Y. Mechanism of ligand recognition by human ACE2 receptor. bioRxiv 2020:2020. [PMID: 33140043 DOI: 10.1101/2020.10.30.362749] [Reference Citation Analysis]
11 Hill LJ, Williams AC. Meat Intake and the Dose of Vitamin B3 - Nicotinamide: Cause of the Causes of Disease Transitions, Health Divides, and Health Futures? Int J Tryptophan Res 2017;10:1178646917704662. [PMID: 28579801 DOI: 10.1177/1178646917704662] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
12 Vianello A, Del Turco S, Babboni S, Silvestrini B, Ragusa R, Caselli C, Melani L, Fanucci L, Basta G. The Fight against COVID-19 on the Multi-Protease Front and Surroundings: Could an Early Therapeutic Approach with Repositioning Drugs Prevent the Disease Severity? Biomedicines 2021;9:710. [PMID: 34201505 DOI: 10.3390/biomedicines9070710] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Herath CB, Mak KY, Angus PW. Role of the Alternate RAS in Liver Disease and the GI Tract. The Protective Arm of the Renin Angiotensin System (RAS). Elsevier; 2015. pp. 239-47. [DOI: 10.1016/b978-0-12-801364-9.00034-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
14 Szychowiak P, Villageois-Tran K, Patrier J, Timsit JF, Ruppé É. The role of the microbiota in the management of intensive care patients. Ann Intensive Care 2022;12:3. [PMID: 34985651 DOI: 10.1186/s13613-021-00976-5] [Reference Citation Analysis]
15 Oliveira LP, Guimarães VHD, Oliveira JR, Guimarães ALS, de Paula AMB, Bader M, Santos RASD, Santos SHS. Genetic deletion of the angiotensin-(1-7) receptor Mas leads to alterations in gut villi length modulating TLR4/PI3K/AKT and produces microbiome dysbiosis. Neuropeptides 2020;82:102056. [PMID: 32505463 DOI: 10.1016/j.npep.2020.102056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Galanopoulos M, Doukatas A, Gazouli M. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract. World J Gastroenterol 2020; 26(41): 6335-6345 [PMID: 33244196 DOI: 10.3748/wjg.v26.i41.6335] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
17 Fairweather SJ, Shah N, Brӧer S. Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology. Adv Exp Med Biol 2021;21:13-127. [PMID: 33052588 DOI: 10.1007/5584_2020_584] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
18 Parpia TC, Elwood SE, Scharf RJ, McDermid JM, Wanjuhi AW, Rogawski McQuade ET, Gratz J, Svensen E, Swann JR, Donowitz JR, Jatosh S, Katengu S, Mdoe P, Kivuyo S, Houpt ER, DeBoer MD, Mduma E, Platts-Mills JA. Baseline Characteristics of Study Participants in the Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT) Trial. Am J Trop Med Hyg 2020;103:1397-404. [PMID: 32783799 DOI: 10.4269/ajtmh.19-0918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Yan T, Xiao R, Lin G. Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword? FASEB J 2020;34:6017-26. [PMID: 32306452 DOI: 10.1096/fj.202000782] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 24.0] [Reference Citation Analysis]
20 Maiuolo J, Mollace R, Gliozzi M, Musolino V, Carresi C, Paone S, Scicchitano M, Macrì R, Nucera S, Bosco F, Scarano F, Zito MC, Ruga S, Tavernese A, Mollace V. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection. Int J Mol Sci 2020;21:E9309. [PMID: 33291346 DOI: 10.3390/ijms21239309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
21 Maghool F, Valiani A, Safari T, Emami MH, Mohammadzadeh S. Gastrointestinal and renal complications in SARS-CoV-2-infected patients: Role of immune system. Scand J Immunol 2021;93:e12999. [PMID: 33190306 DOI: 10.1111/sji.12999] [Reference Citation Analysis]
22 Syed A, Khan A, Gosai F, Asif A, Dhillon S. Gastrointestinal pathophysiology of SARS-CoV2 - a literature review. J Community Hosp Intern Med Perspect. 2020;10:523-528. [PMID: 33194122 DOI: 10.1080/20009666.2020.1811556] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
23 Ramakrishnan RK, Kashour T, Hamid Q, Halwani R, Tleyjeh IM. Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19. Front Immunol 2021;12:686029. [PMID: 34276671 DOI: 10.3389/fimmu.2021.686029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Li Q, Grant MB, Richards EM, Raizada MK. ACE2 as therapeutic agent. Clin Sci (Lond) 2020;134:2581-95. [PMID: 33063820 DOI: 10.1042/CS20200570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
25 Sajdel-Sulkowska EM. A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency. Front Pharmacol 2021;12:684610. [PMID: 34177593 DOI: 10.3389/fphar.2021.684610] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Millar FR, Summers C, Griffiths MJ, Toshner MR, Proudfoot AG. The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities. Thorax 2016;71:462-73. [DOI: 10.1136/thoraxjnl-2015-207461] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 13.2] [Reference Citation Analysis]
27 Zoghi G, Moosavy SH, Yavarian S, HasaniAzad M, Khorrami F, Sharegi Brojeni M, Kheirandish M. Gastrointestinal implications in COVID-19. BMC Infect Dis 2021;21:1135. [PMID: 34736412 DOI: 10.1186/s12879-021-06824-y] [Reference Citation Analysis]
28 de Oliveira AP, Lopes ALF, Pacheco G, de Sá Guimarães Nolêto IR, Nicolau LAD, Medeiros JVR. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route. Med Hypotheses 2020;144:110243. [PMID: 33254549 DOI: 10.1016/j.mehy.2020.110243] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
29 Manosso LM, Arent CO, Borba LA, Ceretta LB, Quevedo J, Réus GZ. Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection. Cells 2021;10:1993. [PMID: 34440767 DOI: 10.3390/cells10081993] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Lu ZH, Zhou HW, Wu WK, Fu T, Yan M, He Z, Sun SW, Ji ZH, Shao ZJ. Alterations in the Composition of Intestinal DNA Virome in Patients With COVID-19. Front Cell Infect Microbiol 2021;11:790422. [PMID: 34900762 DOI: 10.3389/fcimb.2021.790422] [Reference Citation Analysis]
31 Jabczyk M, Nowak J, Hudzik B, Zubelewicz-Szkodzińska B. Diet, Probiotics and Their Impact on the Gut Microbiota during the COVID-19 Pandemic. Nutrients 2021;13:3172. [PMID: 34579048 DOI: 10.3390/nu13093172] [Reference Citation Analysis]
32 Yu Z, Yang Z, Wang Y, Zhou F, Li S, Li C, Li L, Zhang W, Li X. Recent advance of ACE2 and microbiota dysfunction in COVID-19 pathogenesis. Heliyon 2021;7:e07548. [PMID: 34296023 DOI: 10.1016/j.heliyon.2021.e07548] [Reference Citation Analysis]
33 DeBoer MD, Platts-Mills JA, Scharf RJ, McDermid JM, Wanjuhi AW, Gratz J, Svensen E, Swann JR, Donowitz JR, Jatosh S, Houpt ER, Mduma E. Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT): a protocol for a randomised factorial, double-blind, placebo-controlled trial of azithromycin, nitazoxanide and nicotinamide. BMJ Open 2018;8:e021817. [PMID: 29982218 DOI: 10.1136/bmjopen-2018-021817] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
34 Todosenko N, Vulf M, Yurova K, Khaziakhmatova O, Mikhailova L, Litvinova L. Causal Links between Hypovitaminosis D and Dysregulation of the T Cell Connection of Immunity Associated with Obesity and Concomitant Pathologies. Biomedicines 2021;9:1750. [PMID: 34944566 DOI: 10.3390/biomedicines9121750] [Reference Citation Analysis]
35 Bhutia YD, Ganapathy V. Protein Digestion and Absorption. Physiology of the Gastrointestinal Tract. Elsevier; 2018. pp. 1063-86. [DOI: 10.1016/b978-0-12-809954-4.00047-5] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
36 Grobe JL, Sigmund CD. Another Reason to Eat Your Greens: Cardiopulmonary Protection by Dietary Delivery of Angiotensin-Converting Enzyme-2 and Angiotensin-(1-7) Made in Plants. Hypertension 2014;64:1182-3. [DOI: 10.1161/hypertensionaha.114.04075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Sharma RK, Stevens BR, Obukhov AG, Grant MB, Oudit GY, Li Q, Richards EM, Pepine CJ, Raizada MK. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2. Hypertension 2020;76:651-61. [PMID: 32783758 DOI: 10.1161/HYPERTENSIONAHA.120.15595] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
38 Ferreira C, Viana SD, Reis F. Is Gut Microbiota Dysbiosis a Predictor of Increased Susceptibility to Poor Outcome of COVID-19 Patients? An Update. Microorganisms 2020;9:E53. [PMID: 33379162 DOI: 10.3390/microorganisms9010053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
39 Palmeira P, Barbuto JAM, Silva CAA, Carneiro-sampaio M. Why is SARS-CoV-2 infection milder among children? Clinics 2020;75:e1947. [DOI: 10.6061/clinics/2020/e1947] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
40 Lin SY, Ju SW, Lin CL, Lin CC, Hsu WH, Chou CH, Chi CY, Hsu CY, Kao CH. Risk of Viral Infection in Patients Using Either Angiotensin-converting Enzyme Inhibitors or Angiotensin Receptor Blockers: A Nationwide Population-based Propensity Score Matching Study. Clin Infect Dis 2020;71:2695-701. [PMID: 32504531 DOI: 10.1093/cid/ciaa734] [Reference Citation Analysis]
41 Kuriakose J, Montezano AC, Touyz RM. ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease. Clin Sci (Lond) 2021;135:387-407. [PMID: 33511992 DOI: 10.1042/CS20200480] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
42 Bhattarai A, Pawnikar S, Miao Y. Mechanism of Ligand Recognition by Human ACE2 Receptor. J Phys Chem Lett 2021;12:4814-22. [PMID: 33999630 DOI: 10.1021/acs.jpclett.1c01064] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Lv F, Ding XW, Luo ZH, Fang R, Guo QX, Wu CW. Retrospective analysis of digestive system manifestations in patients with coronavirus disease 2019. Shijie Huaren Xiaohua Zazhi 2020; 28(14): 628-636 [DOI: 10.11569/wcjd.v28.i14.628] [Reference Citation Analysis]
44 Gadi N, Wu SC, Spihlman AP, Moulton VR. What's Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses. Front Immunol 2020;11:2147. [PMID: 32983176 DOI: 10.3389/fimmu.2020.02147] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 23.0] [Reference Citation Analysis]
45 Fang LG, Zhou Q. Remarkable gastrointestinal and liver manifestations of COVID-19: A clinical and radiologic overview. World J Clin Cases 2021; 9(19): 4969-4979 [PMID: 34307547 DOI: 10.12998/wjcc.v9.i19.4969] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Annweiler C, Cao Z, Wu Y, Faucon E, Mouhat S, Kovacic H, Sabatier JM. Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients. Infect Disord Drug Targets 2020;20:407-8. [PMID: 32418532 DOI: 10.2174/1871526520666200518073329] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 14.0] [Reference Citation Analysis]
47 Baghbani T, Nikzad H, Azadbakht J, Izadpanah F, Haddad Kashani H. Dual and mutual interaction between microbiota and viral infections: a possible treat for COVID-19. Microb Cell Fact. 2020;19:217. [PMID: 33243230 DOI: 10.1186/s12934-020-01483-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
48 Opazo MC, Ortega-Rocha EM, Coronado-Arrázola I, Bonifaz LC, Boudin H, Neunlist M, Bueno SM, Kalergis AM, Riedel CA. Intestinal Microbiota Influences Non-intestinal Related Autoimmune Diseases. Front Microbiol 2018;9:432. [PMID: 29593681 DOI: 10.3389/fmicb.2018.00432] [Cited by in Crossref: 81] [Cited by in F6Publishing: 63] [Article Influence: 20.3] [Reference Citation Analysis]
49 Carter CS, Morgan D, Verma A, Lobaton G, Aquino V, Sumners E, Raizada M, Li Q, Buford TW. Therapeutic Delivery of Ang(1-7) via Genetically Modified Probiotic: A Dosing Study. J Gerontol A Biol Sci Med Sci 2020;75:1299-303. [PMID: 31586210 DOI: 10.1093/gerona/glz222] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
50 Eroğlu İ, Eroğlu BÇ, Güven GS. Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19). Nutrition 2021;90:111308. [PMID: 34111831 DOI: 10.1016/j.nut.2021.111308] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Duan J, Wu Y, Liu C, Yang C, Yang L. Deleterious effects of viral pneumonia on cardiovascular system. European Heart Journal 2020;41:1833-8. [DOI: 10.1093/eurheartj/ehaa325] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
52 Concas G, Barone M, Francavilla R, Cristofori F, Dargenio VN, Giorgio R, Dargenio C, Fanos V, Marcialis MA. Twelve Months with COVID-19: What Gastroenterologists Need to Know. Dig Dis Sci 2021. [PMID: 34333726 DOI: 10.1007/s10620-021-07158-0] [Reference Citation Analysis]
53 Xu R, Lu R, Zhang T, Wu Q, Cai W, Han X, Wan Z, Jin X, Zhang Z, Zhang C. Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults. Commun Biol 2021;4:240. [PMID: 33603076 DOI: 10.1038/s42003-021-01796-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
54 Oz M, Lorke DE. Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury. Biomed Pharmacother 2021;136:111193. [PMID: 33461019 DOI: 10.1016/j.biopha.2020.111193] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
55 Elgohary S, Elkhodiry AA, Amin NS, Stein U, El Tayebi HM. Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients? Cells 2021;10:302. [PMID: 33540625 DOI: 10.3390/cells10020302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
56 Ye Q, Wang B, Mao J, Fu J, Shang S, Shu Q, Zhang T. Epidemiological analysis of COVID-19 and practical experience from China. J Med Virol. 2020;92:755-769. [PMID: 32237160 DOI: 10.1002/jmv.25813] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 23.0] [Reference Citation Analysis]
57 Zhang H, Li HB, Lyu JR, Lei XM, Li W, Wu G, Lyu J, Dai ZM. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. Int J Infect Dis. 2020;96:19-24. [PMID: 32311451 DOI: 10.1016/j.ijid.2020.04.027] [Cited by in Crossref: 99] [Cited by in F6Publishing: 86] [Article Influence: 49.5] [Reference Citation Analysis]
58 Li Z, Wang K, Ji X, Wang H, Zhang Y. ACE2 suppresses the inflammatory response in LPS-induced porcine intestinal epithelial cells via regulating the NF-κB and MAPK pathways. Peptides 2021;149:170717. [PMID: 34933009 DOI: 10.1016/j.peptides.2021.170717] [Reference Citation Analysis]
59 Perisetti A, Goyal H, Gajendran M, Boregowda U, Mann R, Sharma N. Prevalence, Mechanisms, and Implications of Gastrointestinal Symptoms in COVID-19. Front Med (Lausanne) 2020;7:588711. [PMID: 33195352 DOI: 10.3389/fmed.2020.588711] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
60 Viana SD, Nunes S, Reis F. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis. Ageing Res Rev. 2020;62:101123. [PMID: 32683039 DOI: 10.1016/j.arr.2020.101123] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 18.5] [Reference Citation Analysis]
61 Penninger JM, Grant MB, Sung JJY. The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection. Gastroenterology. 2021;160:39-46. [PMID: 33130103 DOI: 10.1053/j.gastro.2020.07.067] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
62 Onal EM, Afsar B, Covic A, Vaziri ND, Kanbay M. Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease. Hypertens Res 2019;42:123-40. [PMID: 30504819 DOI: 10.1038/s41440-018-0144-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
63 Jin B, Singh R, Ha SE, Zogg H, Park PJ, Ro S. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19. World J Gastroenterol 2021; 27(19): 2341-2352 [PMID: 34040326 DOI: 10.3748/wjg.v27.i19.2341] [Reference Citation Analysis]
64 Gupta D, Sharma P, Singh M, Kumar M, Ethayathulla AS, Kaur P. Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants. Cell Mol Life Sci 2021;78:7967-89. [PMID: 34731254 DOI: 10.1007/s00018-021-04008-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Ceccarelli G, Scagnolari C, Pugliese F, Mastroianni CM, d'Ettorre G. Probiotics and COVID-19. Lancet Gastroenterol Hepatol 2020;5:721-2. [PMID: 32673604 DOI: 10.1016/S2468-1253(20)30196-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
66 Di Renzo L, Gualtieri P, Pivari F, Soldati L, Attinà A, Leggeri C, Cinelli G, Tarsitano MG, Caparello G, Carrano E, Merra G, Pujia AM, Danieli R, De Lorenzo A. COVID-19: Is there a role for immunonutrition in obese patient? J Transl Med 2020;18:415. [PMID: 33160363 DOI: 10.1186/s12967-020-02594-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
67 Hermel M, Sweeney M, Ni YM, Bonakdar R, Triffon D, Suhar C, Mehta S, Dalhoumi S, Gray J. Natural Supplements for COVID19-Background, Rationale, and Clinical Trials. J Evid Based Integr Med 2021;26:2515690X211036875. [PMID: 34384258 DOI: 10.1177/2515690X211036875] [Reference Citation Analysis]
68 Stein RA, Young LM. From ACE2 to COVID-19: A multiorgan endothelial disease. Int J Infect Dis 2020;100:425-30. [PMID: 32896660 DOI: 10.1016/j.ijid.2020.08.083] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
69 Gross LZF, Sacerdoti M, Piiper A, Zeuzem S, Leroux AE, Biondi RM. ACE2, the Receptor that Enables Infection by SARS-CoV-2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators. ChemMedChem 2020;15:1682-90. [PMID: 32663362 DOI: 10.1002/cmdc.202000368] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
70 He F, Wu C, Li P, Li N, Zhang D, Zhu Q, Ren W, Peng Y. Functions and Signaling Pathways of Amino Acids in Intestinal Inflammation. Biomed Res Int. 2018;2018:1-13. [PMID: 29682569 DOI: 10.1155/2018/9171905] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 13.0] [Reference Citation Analysis]
71 Yu W, Ou X, Liu X, Zhang S, Gao X, Cheng H, Zhu B, Yan J. ACE2 contributes to the maintenance of mouse epithelial barrier function. Biochem Biophys Res Commun 2020;533:1276-82. [PMID: 33097186 DOI: 10.1016/j.bbrc.2020.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
72 Yusuf F, Fahriani M, Mamada SS, Frediansyah A, Abubakar A, Maghfirah D, Fajar JK, Maliga HA, Ilmawan M, Emran TB, Ophinni Y, Innayah MR, Masyeni S, Ghouth ASB, Yusuf H, Dhama K, Nainu F, Harapan H. Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: A systematic review and meta-analysis. F1000Res 2021;10:301. [PMID: 34131481 DOI: 10.12688/f1000research.52216.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
73 Ahmad A, Ishtiaq SM, Khan JA, Aslam R, Ali S, Arshad MI. COVID-19 and comorbidities of hepatic diseases in a global perspective. World J Gastroenterol 2021; 27(13): 1296-1310 [PMID: 33833483 DOI: 10.3748/wjg.v27.i13.1296] [Reference Citation Analysis]
74 Semiz S. SIT1 transporter as a potential novel target in treatment of COVID-19. Biomol Concepts 2021;12:156-63. [PMID: 34969185 DOI: 10.1515/bmc-2021-0017] [Reference Citation Analysis]
75 Zhan GF, Wang Y, Yang N, Luo AL, Li SY. Digestive system involvement of infections with SARS-CoV-2 and other coronaviruses: Clinical manifestations and potential mechanisms. World J Gastroenterol 2021; 27(7): 561-575 [PMID: 33642829 DOI: 10.3748/wjg.v27.i7.561] [Reference Citation Analysis]
76 Hammoud SH, Wehbe Z, Abdelhady S, Kobeissy F, Eid AH, El-Yazbi AF. Dysregulation of Angiotensin Converting Enzyme 2 Expression and Function in Comorbid Disease Conditions Possibly Contributes to Coronavirus Infectious Disease 2019 Complication Severity. Mol Pharmacol. 2021;99:17-28. [PMID: 33082267 DOI: 10.1124/molpharm.120.000119] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
77 Chen F, Dai Z, Huang C, Chen H, Wang X, Li X. Gastrointestinal Disease and COVID-19: A Review of Current Evidence. Dig Dis 2021. [PMID: 34510032 DOI: 10.1159/000519412] [Reference Citation Analysis]
78 Pang XC, Zhang HX, Zhang Z, Rinkiko S, Cui YM, Zhu YZ. The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities. Molecules 2020;26:E142. [PMID: 33396184 DOI: 10.3390/molecules26010142] [Reference Citation Analysis]
79 Lu CC, Ma KL, Ruan XZ, Liu BC. Intestinal dysbiosis activates renal renin-angiotensin system contributing to incipient diabetic nephropathy. Int J Med Sci 2018;15:816-22. [PMID: 30008592 DOI: 10.7150/ijms.25543] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
80 El-Arif G, Farhat A, Khazaal S, Annweiler C, Kovacic H, Wu Y, Cao Z, Fajloun Z, Khattar ZA, Sabatier JM. The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19. Molecules 2021;26:6945. [PMID: 34834033 DOI: 10.3390/molecules26226945] [Reference Citation Analysis]
81 Sajdel-Sulkowska EM. Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling. Biomed Res Int 2021;2021:7880448. [PMID: 34651049 DOI: 10.1155/2021/7880448] [Reference Citation Analysis]
82 Duda-Chodak A, Lukasiewicz M, Zięć G, Florkiewicz A, Filipiak-Florkiewicz A. Covid-19 pandemic and food: Present knowledge, risks, consumers fears and safety. Trends Food Sci Technol 2020;105:145-60. [PMID: 32921922 DOI: 10.1016/j.tifs.2020.08.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
83 Guo Y, Wang B, Gao H, Gao L, Hua R, Xu JD. ACE2 in the Gut: The Center of the 2019-nCoV Infected Pathology. Front Mol Biosci 2021;8:708336. [PMID: 34631794 DOI: 10.3389/fmolb.2021.708336] [Reference Citation Analysis]
84 Ingraham NE, Barakat AG, Reilkoff R, Bezdicek T, Schacker T, Chipman JG, Tignanelli CJ, Puskarich MA. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review. Eur Respir J 2020;56:2000912. [PMID: 32341103 DOI: 10.1183/13993003.00912-2020] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 34.5] [Reference Citation Analysis]
85 Chhibber-Goel J, Gopinathan S, Sharma A. Interplay between severities of COVID-19 and the gut microbiome: implications of bacterial co-infections? Gut Pathog 2021;13:14. [PMID: 33632296 DOI: 10.1186/s13099-021-00407-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
86 Yang P, Gu H, Zhao Z, Wang W, Cao B, Lai C, Yang X, Zhang L, Duan Y, Zhang S, Chen W, Zhen W, Cai M, Penninger JM, Jiang C, Wang X. Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury. Sci Rep. 2014;4:7027. [PMID: 25391767 DOI: 10.1038/srep07027] [Cited by in Crossref: 156] [Cited by in F6Publishing: 147] [Article Influence: 19.5] [Reference Citation Analysis]
87 Khan M, Mathew BJ, Gupta P, Garg G, Khadanga S, Vyas AK, Singh AK. Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19. Microorganisms 2021;9:1292. [PMID: 34199203 DOI: 10.3390/microorganisms9061292] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Martín Giménez VM, Ferder L, Inserra F, García J, Manucha W. Differences in RAAS/vitamin D linked to genetics and socioeconomic factors could explain the higher mortality rate in African Americans with COVID-19. Ther Adv Cardiovasc Dis 2020;14:1753944720977715. [PMID: 33283618 DOI: 10.1177/1753944720977715] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
89 Pekmez CT, Dragsted LO, Brahe LK. Gut microbiota alterations and dietary modulation in childhood malnutrition - The role of short chain fatty acids. Clin Nutr 2019;38:615-30. [PMID: 29496274 DOI: 10.1016/j.clnu.2018.02.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
90 Figueroa-Pizano MD, Campa-Mada AC, Carvajal-Millan E, Martinez-Robinson KG, Chu AR. The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: a critical review. AIMS Public Health 2021;8:720-42. [PMID: 34786431 DOI: 10.3934/publichealth.2021057] [Reference Citation Analysis]
91 Manickam C, Sugawara S, Reeves RK. Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020. PLoS Pathog 2020;16:e1008820. [PMID: 32845937 DOI: 10.1371/journal.ppat.1008820] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
92 Ren Z, Wang H, Cui G, Lu H, Wang L, Luo H, Chen X, Ren H, Sun R, Liu W, Liu X, Liu C, Li A, Wang X, Rao B, Yuan C, Zhang H, Sun J, Chen X, Li B, Hu C, Wu Z, Yu Z, Kan Q, Li L. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut 2021;70:1253-65. [PMID: 33789966 DOI: 10.1136/gutjnl-2020-323826] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
93 D'Ardes D, Boccatonda A, Rossi I, Guagnano MT, Santilli F, Cipollone F, Bucci M. COVID-19 and RAS: Unravelling an Unclear Relationship. Int J Mol Sci 2020;21:E3003. [PMID: 32344526 DOI: 10.3390/ijms21083003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 15.5] [Reference Citation Analysis]
94 Patten GS, Abeywardena MY. Effects of Antihypertensive Agents on Intestinal Contractility in the Spontaneously Hypertensive Rat: Angiotensin Receptor System Downregulation by Losartan. J Pharmacol Exp Ther 2017;360:260-6. [PMID: 27903643 DOI: 10.1124/jpet.116.237586] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
95 Barengolts E, Smith ED. Considerations for Gut Microbiota and Probiotics in Patients with Diabetes Amidst the Covid-19 Pandemic: A Narrative Review. Endocr Pract 2020;26:1186-95. [PMID: 33471720 DOI: 10.4158/EP-2020-0336] [Reference Citation Analysis]
96 Ahlawat S, Asha, Sharma KK. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection. Virus Res 2020;286:198103. [PMID: 32717345 DOI: 10.1016/j.virusres.2020.198103] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 15.5] [Reference Citation Analysis]
97 Verma A, Xu K, Du T, Zhu P, Liang Z, Liao S, Zhang J, Raizada MK, Grant MB, Li Q. Expression of Human ACE2 in Lactobacillus and Beneficial Effects in Diabetic Retinopathy in Mice. Mol Ther Methods Clin Dev 2019;14:161-70. [PMID: 31380462 DOI: 10.1016/j.omtm.2019.06.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
98 Liao W, Wu J. The ACE2/Ang (1-7)/MasR axis as an emerging target for antihypertensive peptides. Crit Rev Food Sci Nutr 2021;61:2572-86. [PMID: 32551837 DOI: 10.1080/10408398.2020.1781049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
99 Jabczyk M, Nowak J, Hudzik B, Zubelewicz-Szkodzińska B. Microbiota and Its Impact on the Immune System in COVID-19-A Narrative Review. J Clin Med 2021;10:4537. [PMID: 34640553 DOI: 10.3390/jcm10194537] [Reference Citation Analysis]
100 Perisetti A, Gajendran M, Goyal H. Putative Mechanisms of Diarrhea in COVID-19. Clin Gastroenterol Hepatol. 2020;18:3054-3055. [PMID: 32535231 DOI: 10.1016/j.cgh.2020.06.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
101 Bianco F, Incollingo P, Grossi U, Gallo G. Preventing transmission among operating room staff during COVID-19 pandemic: the role of the Aerosol Box and other personal protective equipment. Updates Surg 2020;72:907-10. [PMID: 32449034 DOI: 10.1007/s13304-020-00818-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
102 İkiz Ö, Kahramansoy N, Erkol H, Koçoğlu E, Fırat T. Effects of lycopene in intestinal ischemia reperfusion injury via intestinal immunoglobulin A. J Surg Res 2021;267:63-70. [PMID: 34130240 DOI: 10.1016/j.jss.2021.04.039] [Reference Citation Analysis]
103 Johnson SD, Olwenyi OA, Bhyravbhatla N, Thurman M, Pandey K, Klug EA, Johnston M, Dyavar SR, Acharya A, Podany AT, Fletcher CV, Mohan M, Singh K, Byrareddy SN. Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis. World J Gastroenterol 2021; 27(29): 4763-4783 [PMID: 34447225 DOI: 10.3748/wjg.v27.i29.4763] [Reference Citation Analysis]
104 Brown SA, Zaharova S, Mason P, Thompson J, Thapa B, Ishizawar D, Wilkes E, Ahmed G, Rubenstein J, Sanchez J, Joyce D, Kalyanaraman B, Widlansky M. Pandemic Perspective: Commonalities Between COVID-19 and Cardio-Oncology. Front Cardiovasc Med 2020;7:568720. [PMID: 33344513 DOI: 10.3389/fcvm.2020.568720] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]